98%
921
2 minutes
20
Designing composites based on natural polymers has attracted attention for more than a decade due to the possibility to manufacture medical devices which are biocompatible with the human body. Herein, we present some biomaterials made up of collagen, polyurethane, and cellulose doped with lignin and lignin-metal complex, which served as transcutaneous drug delivery systems. Compared with base material, the compressive strength and the elastic modulus of biocomposites comprising lignin or lignin-metal complex were significantly enhanced; thus, the compressive strength increased from 61.37 to 186.5 kPa, while the elastic modulus increased from 0.828 to 1.928 MPa. The release of ketokonazole from the polymer matrix follows a Korsmeyer-Peppas type kinetics with a Fickian diffusion. All materials tested were shown to be active against pathogenic microorganisms. The mucoadhesiveness, bioadhesiveness, mechanical resistance, release kinetic, and antimicrobial activity make these biocomposites to be candidates as potential systems for controlled drug release.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199638 | PMC |
http://dx.doi.org/10.3390/polym13111845 | DOI Listing |
Int J Biol Macromol
September 2025
Department of Molecular Science & Technology, Ajou University, Suwon 16499, South Korea; Advanced College of Bio-Convergence Engineering, Ajou University, Suwon 16499, South Korea. Electronic address:
Self-assembled hyaluronic acid nanoparticles (HANPs) exhibit promising therapeutic effects against psoriasis, yet their precise targets and molecular mechanisms remain inadequately explored. Here, we demonstrate that HANPs target toll-like receptor 2 (TLR2) to alleviate psoriatic skin inflammation in preclinical settings. This action is mediated by the HA-derived hydrophilic shell surrounding the NPs, rather than free HA or the hydrophobic core.
View Article and Find Full Text PDFFront Pharmacol
August 2025
Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia, Jinan, China.
In recent years, dissolving MNS technology, as an emerging transdermal drug delivery technology, has shown unique advantages and broad application prospects in the fields of transdermal drug delivery, transcutaneous immunity, beauty and skin care, food testing, and disease diagnosis. The active ingredients of traditional Chinese medicine have shown remarkable efficacy in treating various diseases. However, the mode of administration of traditional Chinese medicine (TCM) limits its potential for clinical application and promotion to a certain extent.
View Article and Find Full Text PDFSci Rep
August 2025
Faculty of Medicine and Health Science, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.
Analgesics and anti-inflammatory drugs represent the largest segment of over-the-counter (OTC) medicines. This observational study involved 247 patients treated for pain in outpatient physiotherapy. Using Transcutaneous Electrical Nerve Stimulation (TENS) sensitivity threshold was measured together with subjective sensation (hedonic rating), investigating the impact of OTC analgesic intake on sensory sensitivity and subjective perception.
View Article and Find Full Text PDFContemp Clin Trials
September 2025
University of Iowa College of Nursing, Iowa City, IA, United States of America.
Background: Chronic pain affects over 50 million Americans and is the main reason for primary care consultations. Clinical practice guidelines recommend use of non-drug therapies as first-line treatments. However, adoption and implementation of these guidelines are hindered by logistics.
View Article and Find Full Text PDFObjective: Tremor is a common presenting concern and is associated with a wide range of potential etiologies. This article reviews the approach to the clinical evaluation of tremor, the diagnosis of essential tremor, differential diagnoses, and management options.
Latest Developments: Although new investigational drugs are being studied, no medication besides propranolol has been approved by the US Food and Drug Administration (FDA) as a treatment for essential tremor.